Yeon Hee Lee

Title: Yeon Hee Lee: Innovator in Neoagaro-Oligosaccharides Production

Introduction: Yeon Hee Lee is a notable inventor based in Seongnam-si, South Korea. He has made significant contributions to the field of biotechnology, particularly in the production of neoagaro-oligosaccharides. His innovative work has implications for various applications in food and pharmaceutical industries.

Latest Patents: Yeon Hee Lee holds a patent for a mutant strain and method of producing β-agarase. The patent describes strain A3(2)_M22-2C43, which was developed by inducing a point mutation in the base sequence of the DagB gene in a wild-type strain A3(2) through UV radiation. This strain expresses a DagB mutant enzyme that exhibits little or no β-agarase activity. As a result, there is no need for separate isolation and purification of DagA enzymes from culture fluid. The culture fluid or supernatant from strain A3(2)_M22-2C43 can be utilized to produce neoagarose oligosaccharides with a higher content of neoagarotetraose or neoagarohexaose than that of neoagarobiose.

Career Highlights: Yeon Hee Lee is currently associated with Dynebio Inc., where he continues to advance his research and development efforts. His work has garnered attention for its potential to enhance the efficiency of oligosaccharide production processes.

Collaborations: Yeon Hee Lee collaborates with talented individuals in his field, including Je Hyeon Lee and Eun Joo Kim. Their combined expertise contributes to the innovative projects at Dynebio Inc.

Conclusion: Yeon Hee Lee's contributions to biotechnology, particularly in the production of neoagaro-oligosaccharides, highlight his role as an influential inventor. His patented work demonstrates the potential for advancements in the industry, paving the way for future innovations.